Theravance Biopharma has developed FDA-approved drugs and is currently developing a therapy for MSA patients.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Theravance Biopharma (United States) →

  company in San Francisco, United States

  Nothing else this week.

• MSA →

  Czech company

  Nothing else this week.

Related events

• Iovance Biotherapeutics received FDA approval for its therapy, and the company is listed on Nasdaq.Jun 20
• The FDA has approved a drug developed by Cytokinetics for its intended use as a treatment.Jun 16
• The FDA, Marathon Pharmaceuticals, and Biogen are leading the pre- and post-approval strategy and integrated medical launches for Multiple Sclerosis (MS).Sep 8
• Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.Aug 18
• A company plans to submit regulatory applications to the FDA, EMA, and Australian TGA.Thu 13:53